At luncheon presentations in Stockholm and Oslo, the team behind Arctic Aurora LifeScience fund has presented the fund’s Sustainability Strategy with a special focus on ”Sustainable Biotech”. The report is authored by Stanford student Thea Rosenberg together with Ulrica Slåne Bjerke, CIO of the fund.
During 2018, the Arctic Aurora LifeScience Team has worked on an extensive report addressing Responsbile Investments in the Life Science sector. The report was presented by CIO in Arctic Aurora LifeScience, Ulrica Bjerke, and coauthor Thea Rosenberg of Stanford University.
”Defining sustainability in the biotech sector and working with the companies is an ongoing process, this is a start” says Ulrica Slåne Bjerke.
The report was presented in both Stockholm and Oslo during the week of 20th of November. The team would also like to pass on a special thanks to Christina Hillesöy, Head of Sustainability at Länsförsäkringar AB, for valuable advice.
Please download the report in full for insight into "Responsible Investments in Life Science".
Arctic Aurora LifeScience is an equity fund investing in global biotechnology and pharmaceutical companies. The fund is run by former portfolio manager in the Swedish Governmental Pension Fund AP3, Ulrica Bjerke, as well as Dr. Torbjørn Bjerke, both with 20 years of experience from the market. Arctic Aurora LifeScience was launched in May 2016 with both hedged and un-hedged share classes.
Past performance in Arctic Aurora LifeScience is no guarantee for future returns. Future returns depend on the market, fund manager skill, fund risk level, costs, among others. Performance in the fund may at times be negative and may for this fund vary considerably within periods.